Search

everythinglearnresearchcommunity

for

Search:↓

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Anti-CD19 therapy may help treat SLE and NMOSD.

Atypical symptoms in lupus can indicate different kidney issues.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

New treatments and understanding of skin lupus are emerging in 2024.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Quality of life improved after COVID-19, but ongoing health support is needed.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

Vaccination is the most effective way to reduce COVID-19 transmission.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.